148 related articles for article (PubMed ID: 7207826)
1. [Effects of naftidrofuryl through prolonged intra-arterial perfusion in obliterating arteriopathies of the lower limbs].
Cospite M; Ferrara F; Ballo M; Lo Presti T; Raimondi F; Meli F; Milio G
Minerva Cardioangiol; 1980 May; 28(5):359-66. PubMed ID: 7207826
[No Abstract] [Full Text] [Related]
2. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
Schmidt C; Royer RJ; Kissel P
Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
[No Abstract] [Full Text] [Related]
3. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
Ranft J; Heidrich H; Lammersen T
J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
[TBL] [Abstract][Full Text] [Related]
4. [Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
Ciammaichella A; Solitro A; Arcuri P
Minerva Cardioangiol; 1975 Oct; 23(10):607-21. PubMed ID: 1232566
[No Abstract] [Full Text] [Related]
5. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
[No Abstract] [Full Text] [Related]
6. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
Horsch S
Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
[No Abstract] [Full Text] [Related]
7. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A; Karnik R; Stöllberger C; Slany J
Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
[No Abstract] [Full Text] [Related]
8. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
Abendroth D; Sunder-Plassmann L
Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
[No Abstract] [Full Text] [Related]
9. [The effect of naftidrofuryl on platelet aggregation].
Sensale P
Acta Neurol Quad (Napoli); 1980; 41():86-92. PubMed ID: 7293743
[No Abstract] [Full Text] [Related]
10. Naftidrofuryl in the treatment of recent stroke. Results of a controlled clinical trial.
Steiner TJ
Vasa Suppl; 1988; 24():44-7. PubMed ID: 3062824
[No Abstract] [Full Text] [Related]
11. [Clinical effectiveness of naftidrofuryl in intermittent claudication].
Kriessmann A; Neiss A
Vasa Suppl; 1988; 24():27-32. PubMed ID: 3062823
[No Abstract] [Full Text] [Related]
12. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg.
Adhoute G; Bacourt F; Barral M; Cardon JM; Chevalier JM; Cuny A; Gillet M; Juhan C; Leguay G; Marion J
Angiology; 1986 Mar; 37(3 Pt 1):160-7. PubMed ID: 3518547
[TBL] [Abstract][Full Text] [Related]
13. [Can the progression of arteriosclerosis be influenced pharmaco- logically?].
Rudofsky G; Hirche H; Drück A; Altenhoff B
Vasa Suppl; 1988; 24():67-75. PubMed ID: 3062826
[No Abstract] [Full Text] [Related]
14. [Naftidrofuryl in cerebrovascular sclerosis. Ophthalmodynamic findings in acute and long term experiment].
Finke J; Kettlitz UP
ZFA (Stuttgart); 1976 Sep; 52(27):1400-3. PubMed ID: 790807
[No Abstract] [Full Text] [Related]
15. Effects of naftidrofuryl on pathological EEG topography.
Foit A; Bischoff W; Breinlinger U; Kornhuber HH
Vasa Suppl; 1988; 24():56-9. PubMed ID: 3212605
[No Abstract] [Full Text] [Related]
16. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
Grossmann W; Standl A; May U
Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
[No Abstract] [Full Text] [Related]
17. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
Pointel JP; Thomas C; Mosnier M; Percebois G; Debry G
Angiology; 1986 Sep; 37(9):647-53. PubMed ID: 3767072
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of blood flow changes in chronic peripheral ischemia in relation to surgical or pharmacological hyperemizing therapy].
Florena M; Cortese LF; Ruscazio M
Minerva Cardioangiol; 1979; 27(1-2):51-60. PubMed ID: 471236
[No Abstract] [Full Text] [Related]
19. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
Ratschow R
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
[TBL] [Abstract][Full Text] [Related]
20. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice.
Brodie NH
Practitioner; 1977 Feb; 218(1304):274-9. PubMed ID: 320593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
